restoring the defective metabolic process. Alexion initiated the rolling submission of a BLA to the FDA in April 2014. The European Medicines Agency validated the company's MAA and granted accelerated assessment in July 2014. Post your comment!
MAA (NYSE: MAA ) declares $0.73/share quarterly dividend , in line with previous. Forward yield 4.12% Payable Oct. 31; for shareholders of record Oct. 15; ex-div Oct. 13. Post your comment!
Amgen (NASDAQ: AMGN ) submits a Marketing Authorization Application to Europe's EMA for evolocumab for the treatment of high cholesterol. Evolocumab is inhibits proprotein convertase subtilis/kexin type 9 ( PCSK9 ), a protein that reduces the liver's ability to remove low-density lipoprotein ...
Amgen (NASDAQ: AMGN ) submits a Marketing Authorization Application to the European Medicines Agency (EMA) for talimogene laherparepvec (TL) for the treatment of adult patients with melanoma that is regionally or distantly metastatic. TL is an investigational oncolytic immunotherapy administered as
Current therapies act only to block the harmful effects. Novartis intends to submit its NDA to the FDA by the end of 2014 and its MAA to the EC in early 2015. Related tickers: (NYSE: VRX ) (NYSE: TEVA ) (NASDAQ: MYL ) (NYSE: TARO ) (NYSE: RDY ) Post
By Dane Bowler : In this series of articles, we take a dive into REIT valuations across the various sectors to determine where there is still opportunity for outperformance. Part 1 covered healthcare , part 2 covered industrials and the focus of this article will be on residential REITs. ...
Started with Buys are Mid - America Apartment Communities ( MAA -0.1% ), and Camden Property Trust ( CPT ), and initiated at Neutral are Home Properties ( HME -0.4% ), and UDR ( UDR ). Post your comment!
The European Medicines Agency accepts Cubist Pharmaceuticals' (NASDAQ: CBST ) Marketing Authorization Application for ceftolozane/tazobactam for the treatment of complicated urinary tract infections and complicated intra-abdominal infections. The European Commission should announce its decision by
more than $900M after racking up big gains in the stocks this year. The biggest reductions were in Mid - America Apartment Communities ( MAA +0.3% ), AvalonBay ( AVB +0.8% ), and Equity Lifestyle Properties ( ELS +0.2% ), and
Residential (NYSE: EQR ) and AvalonBay (NYSE: AVB ) are at all-time highs, but their owners may want to mull the fast pace of building. Others of interest: ESS , PPS , UDR , AIV , CPT , HME , MAA , TSRE , AEC , IRET , APTS Post your comment!